Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

5.61
Delayed Data
As of 1:09pm ET
 -0.13 / -2.26%
Today’s Change
4.21
Today|||52-Week Range
12.47
-22.08%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close5.74
Today’s open5.69
Day’s range5.53 - 5.69
Volume10,124
Average volume (3 months)74,986
Market cap$159.9M
Dividend yield--
Data as of 1:09pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)+4.41%
Earnings growth (this year)+4.52%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.62%
P/E ratioNM
Price/Sales3.78
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...-0.06-1.93%
TROVTrovagene Inc-0.13-3.26%
CALACalithera Bioscience...-0.07-1.31%
TRILTrillium Therapeutic...-0.03-0.28%
Data as of 1:26pm ET, 05/03/2016

Financials

Next reporting dateMay 6, 2016
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$49.5M
Annual profit (last year)-$33.7M
Net profit margin-68.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs